2019
DOI: 10.1093/nar/gkz344
|View full text |Cite
|
Sign up to set email alerts
|

c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer

Abstract: The splicing factor Sam68 is upregulated in many human cancers, including prostate cancer (PCa) where it promotes cell proliferation and survival. Nevertheless, in spite of its frequent upregulation in cancer, the mechanism(s) underlying its expression are largely unknown. Herein, bioinformatics analyses identified the promoter region of the Sam68 gene (KHDRBS1) and the proto-oncogenic transcription factor c-MYC as a key regulator of Sam68 expression. Upregulation of Sam68 and c-MYC correlate in PCa patients. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(30 citation statements)
references
References 50 publications
0
30
0
Order By: Relevance
“…SP1‐induced LINC00511 enhances glioma progression by targeting miR‐124‐3p/CCND2 axis (Li et al, 2019). c‐MYC allows transcription and splicing of the carcinogenic splicing factor Sam68 in cancer (Caggiano et al, 2019). Thereafter, we continued to attest the modulatory mechanism underlying miR‐4429 in CRC.…”
Section: Discussionmentioning
confidence: 99%
“…SP1‐induced LINC00511 enhances glioma progression by targeting miR‐124‐3p/CCND2 axis (Li et al, 2019). c‐MYC allows transcription and splicing of the carcinogenic splicing factor Sam68 in cancer (Caggiano et al, 2019). Thereafter, we continued to attest the modulatory mechanism underlying miR‐4429 in CRC.…”
Section: Discussionmentioning
confidence: 99%
“…Few studies have investigated the molecular mechanisms driving alterations in SR protein levels, which, in tumors, frequently occurs without genomic copy number changes (Best et al, 2013;Karni et al, 2007;Park et al, 2019;Sebestyé n et al, 2016), arguing for misregulation at the post-transcriptional level. Transcriptional activation of SFs, for example by the Myc oncogene, occurs in a subset of tumors (Anczukó w et al, 2012;Caggiano et al, 2019;Das et al, 2012;David et al, 2010;Koh et al, 2015;Park et al, 2019). Therefore, investigation of the fundamental mechanisms that regulate the AS machinery is imperative.…”
Section: Introductionmentioning
confidence: 99%
“…Transcription factors are known as regulators of genes in nucleus [ 34 ]. Here, we predicted the potential upstream transcription factors of LINC00667 by using the online tool ALGGEN.…”
Section: Resultsmentioning
confidence: 99%